The cellular localization of the L-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems

Progress in Neurobiology

Volumn 57, Issue 5, 1999, Pages 485-505

  Bernstein, Hans Gert ^a   Müller, Michael ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; EFLORNITHINE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROLEPTIC AGENT; ORNITHINE DECARBOXYLASE; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; ENZYME LOCALIZATION; GLIA CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KINDLING; NERVE CELL; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA; SEIZURE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; NEURONS; ORNITHINE DECARBOXYLASE; POLYAMINES; PUTRESCINE; REFERENCE VALUES; SPERMIDINE; SPERMINE;

EID: 0344628699     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00065-3     Document Type: Review

References (183)

1. Alcivar A. A., Hake L. E., Mali P., Kaipia A., Parvinen M., Hecht N. B. Developmental and differential expression of the ornithine decarboxylase gene in rodent testis. Biol. Reprod. 41:1989;1133-1142.
2. Anderson T. R., Schanberg S. M. Ornithine decarboxylase activity in developing rat brain. J. Neurochem. 19:1972;1471-1481.
3. Anehus S., Emanuelsson H., Persson L., Sundler F., Scheffler I. E., Heby O. Localization of ornithine decarboxylase in mutant CHO cells that overproduce the enzyme. Differences between the intracellular distribution of monospecific ornithine decarboxylase antibodies and radiolabeled alpha-difluoromethylornithine. Eur. J. Cell. Biol. 35:1984;264-272.
4. Bartholeyns J. Subcellular distribution of ornithine decarboxylase in rat liver and accessibility of the enzyme to alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Life Sci. 32:1983;1305-1312.
5. Bartholome J., Schweitzer V., Slotkin T. A., Nadler J. V. Impaired development of cerebellar cortex in rats treated postnatally with alpha-difluoromethylornithine. Neuroscience. 15:1985;203-213.
6. Baudry M., Lynch G., Gall C. Induction of ornithine decarboxylase as a possible mediator of seizure-elicited changes in genomic expression in rat hippocampus. J. Neurosci. 6:1986;3430-3435.
7. Becker A., Grecksch G., Brosz M. Naloxone ameliorates the learning deficit induced by pentylenetetrazol kindling in rats. Eur. J. Neurosci. 6:1994;1512-1515.
8. Bell J. M., Slotkin T. A. Polyamines as intermediates in developmental neurotoxic events. Neurotoxicology. 7:1986;350-355.
9. Bernaudin M., Nouvelet A., MacKenzie E. T., Petit E. Selective vulnerability and specific glial reaction in hippocampal and neocortical organotypic cultures submitted to ischemia. Exp. Neurol. 150:1998;30-39.
10. Bernstein H.-G., Müller M. Increased immunostaining for ornithine decarboxylase occurs in neocortical neurons of Alzheimer disease patients. Neurosci. Lett. 186:1995;12-126.
11. Bernstein H.-G., Grecksch G., Rüthrich H., Müller M., Becker A., Pajunen A. E. I. Long-lasting expression of ornithine decarboxylase immunoreactivity in rat brain astrocytes after pentylenetetrazol-induced chemical kindling. Neurosci. Res. Commun. 16:1995;83-88.
12. Bernstein H-G., Rüthrich H-L., Rauca C., Krug M., Wiederanders B., Pajunen A. Moderate hypoxia reduces pentylenetetrazol-induced seizures: in search of cellular mechanisms. Ann. Anat. Suppl. 178:1996;115.
13. Bernstein H.-G., Henning H., Danos P., Krell D., Falkai P., Stark H., Baumann B., Bogerts B. A morphometric and immunohistochemical study of the rostral entorhinal cortex in neuropsychiatric patients and controls: heterotopically displaced lamina II neurons are not indicative of schizophrenia. Soc Neurosci. Abstr. 854.2:1997;0.
14. Bernstein H-G., Grecksch G., Becker A., Höllt V., Bogerts B. Postnatal lesions by ibotenic acid of the ventral hippocampus in rats: morphofunctional consequences. Pharmacopsychiatry. 31:1998;9.
15. Bettuzzi S., Marinelli M., Strocchi P., Cevolani D., Corti A. Different localization of spermidine/spermine N1-acetyltransferase and ornithine decarboxylase transcripts in the rat kidney. FEBS Lett. 27:1995;321-324.
16. + channels of their membrane. Glia. 23:1998;209-220.
17. Blackshaer P. J., Manzella J. M., Stumpo D. J., Wen J., Huang J. K., Oyen O., Young W. S. High level, cell specific expression of ODC on rat genitourinary tissues. Mol. Endocrinol. 3:1989;68-78.
18. Bogerts B. The temporolimbic theory of positive schizophrenic symptoms. Schizophr. Bull. 23:1997;423-435.
19. Borlongan C. V., Cahill D. W., Freeman T. B., Sanberg P. R. Recent advances in neural transplantation: relevance to neurodegenerative disorders. J. Fla. Med. Ass. 811:1994;649-694.
20. Borlongan C. V., Koutouzis T. K., Jorden J. R., Martinez R., Rodriguez A. I., Polos S. G., Freeman T. B., McKeown P., Cahill D. W., Nishino H., Sanberg P. R. Neural transplantation as an experimental treatment modality for cerebral ischemia. Neurosci. Biobehav. Rev. 21:1997;79-90.
21. Bragin A., Takacs J., Vinogradova O., Zhuravleva Z., Hamori J. Number of GABA-immunopositive and GABA-immunonegative neurons in various types of neocortical tranplants. Exp. Brain Res. 85:1991;114-118.
22. Calo M., Gratteri S., Fersini G., de Sarro G. B. Neuropathological lesions and ECoG changes of putrescine after microinfusion in the third cerebral ventricle and in several areas of the rat brain. Clin. Vet. 4:1988;238-246.
23. Casero R. A., Gabrielson E. W., Pegg A. E. Immunohistochemical staining of human spermidine/spermine N1-acetyltransferase superinduced in response to treatment wirh antitumor polyamine analogues. Cancer Res. 54:1994;3955-3958.
24. Chan P. H. Editorial comment to the paper of Lukkarinen et al. Stroke. 28:1997;645.
25. Cintra A., Fuxe K., Agnati L. F., Harfstrand A., Zoli M., Eneroth P., Zini I. Evidence for the existence of ornithine decarboxylase immunoreactive neurons in rat brain. Neurosci. Lett. 76:1987;269-274.
26. Cremers A. F., Jansen in de Wal N., Wiegant J., Dirks R. W., Weisbeek P., van der Ploeg M., Landegent J. E. Non-radioactive in situ hybridization. A comparison of several immunocytochemical detection systems using reflection-contrast and electron microscopy. Histochemistry. 86:1987;609-615.
27. Crutcher K. A., Scott S. A., Liang S., Everton W. V., Kleingardner J. Detection of NGF-like activity in human brain tissue-increased levels in Alzheimer's disease. J. Neurosci. 13:1993;2540-2550.
28. Das I. Effect of neuroleptic drugs on polyamine synthesis in human neutrophils in vitro. Biochem. Soc. Trans. 22:1994;185S.
29. Demsey R. J., Maley B. E., Cowen D., Olson J. W. Ornithine decarboxylase activity and immunohistochemical location in postischemic brain. J. Cerebr. Blood Flow Metab. 8:1988;843-847.
30. De Vera N., Camon L. L., Martinez E. Blood polyamines after status epilepticus by kainic acid in the rat. Biogenic Amines. 11:1995;165-176.
31. Dodds R. A., Pitsillides A. A., Frost G. T. B. A quantitative cytochemical method for ornithine decarboxylase activity. J. Histochem. Cytochem. 38:1990;123-127.
32. Dorn A., Müller M., Bernstein H.-G., Pajunen A., Järvinen M. Rat prostate gland - a good model for demonstration of ornithine decarboxylase by immunohistochemistry. Histochem. J. 17:1985;731-733.
33. Dorn A., Müller M., Bernstein H.-G., Pajunen A., Järvinen M. Immunohistochemical demonsration of ornithine decarboxylase in developing rat kidney. Acta Histochem. Cytochem. 18:1985;337-341.
34. Dorn A., Bernstein H.-G., Müller M., Ziegler M., Järvinen M., Pajunen A. Remarkable localization of ornithine decarboxylase in rat pancreas. Eur. J. Cell. Biol. 41:1986;127-129.
35. Dorn A., Müller M., Bernstein H.-G., Pajunen A., Järvinen M. Immunohistochemical localization of ornithine decarboxylase in developing rat brain. Int. J. Dev. Neurosci. 5:1987;145-150.
36. Flamigni F., Stanic I., Stefanelli, Muscari C., Giaccari A., Rossoni C. Inhibition of the expression of ornithine decarboxylase by haloperidol in difluoromethylornithine-resistant leukemia cells. Biochem. Pharmac. 52:1996;1393-1397.
37. Flayeh K. A. Spermidine oxidase activity in serum of normal and schizophrenic subjects. Clin. Chem. 34:1988;401-403.
38. Fozard J. R., Port M. L., Prakash N. J., Grove J., Schechter P. J., Sjoerdsma A., Koch-Weser J. L-Ornithine decarboxylase: an essential role in early mammalian embryogenesis. Science. 208:1980;505-508.
39. Frölich L., Blum-Degen D., Bernstein H.-G., Engelsberger S., Humrich J., Laufer S., Muschner D., Thalheimer A., Türk A., Hoyer S., Zöchling R., Boissl K. W., Jellinger K., Riederer P. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural Transm. 105:1998;423-438.
40. Fujiwara K., Bai G., Kitagawa T. Polyamine-like immunoreactivity in rat neurons. Brain Res. 767:1997;166-171.
41. Gilad G. M., Gilad V. H. Histochemical localization of ornithine decarboxylase with a labelled suicidal enzyme inhibitor. Biochem. Biophys. Res. Commun. 96:1980;1312-1316.
42. Gilad G. M., Gilad V. H. Polyamines can protect against ischemia-induced nerve cell death in gerbil forebrain. Exp. Neurol. 111:1991;349-355.
43. Gilad G. M., Gilad V. H. Polyamines in neurotrauma: ubiquitous molecules in search of a function. Biochem. Pharmac. 44:1992;401-407.
44. Gilad G. M., Gilad V. H., Casanova M. F., Casero R. A. Jr. Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders. Biol. Psychiat. 38:1995;227-234.
45. Gilad G. M., Gilad V. H., Rabey J. M. Arginine and ornithine decarboxylastion in rodent brain-coincidental changes during development and after ischemia. Neurosci. Lett. 216:1996;33-36.
46. Gonzalez Deniselle M. C., Gonzalez S., Piroli G., Ferrini M., Lima A. E., De Nicola A. F. Glucocorticoid receptors and actions in the spinal cord of the Wobbler mouse, a model for neurodegenerative diseases. J. Steroid Biochem. Mol. Biol. 60:1997;205-213.
47. Gritli-Linde A., Linde A. Localization of ornithine decarboxylase in mouse teeth. An in vitro and in vivo study. Int. J. Dev. Biol. 38:1994;107-115.
48. Gutierrez-Pena E. J., Buttner D. W., Müller S. Oncocera volvulus: immunohistochemical and immunoelectron microscopical distribution of polyamine oxidizing enzyme. Trop. Med. Int. Health. 2:1997;472-481.
49. Halonen T., Sivenius J., Miettinen R., Halmekytö M., Kauppinen R., Sinevirta R., Alakuijala L., Alhonen L., MacDonald E., Jänne J., Riekkinen P. J. S. Elevated seizure threshold and impaired spatial learning in transgenic mice with putrescine overproduction in the brain. Eur. J. Neurosci. 5:1993;1233-1239.
50. Hayashi, S. (1989) Ornithine Decarboxylase: Biology, Enzymology, and Molecular Genetics, pp. 147-160. Pergamon Press, New York.
51. Hayashi S., Murakami Y., Matsufuji S. Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem. Sci. 21:1996;27-30.
52. Hayashi Y., Hattori Y., Hori Y. Involvement of putrescine in the development of kindled seizure in rats. J. Neurochem. 58:1992;562-566.
53. Hayashi Y., Hattori Y., Moriwaki A., Lu Y.-F., Hori Y. Increases in polyamine concentrations in chemical kindling and single convulsion induced by pentylentetrazol in rats. Neurosci. Lett. 149:1993;63-66.
54. Heby O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation. 19:1981;1-20.
55. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25:1994;1418-1435.
56. Herberg L.J., Rose I.C., de Belleroche J.S., Mintz M. Ornithine decarboxylase and polyamine synthesis in the kindling of seizures: the effect of alpha-difluoromethylornithine. Epilepsy Res. 11:1992;3-7.
57. Hietala O. A. Regulatory aspects of polyamine metabolism in mouse brain. Acta univ. Ouluensis. 158:1983;1-97.
58. Hirsch S. R., Barnes T. R. Testing the efficacy of new neuroleptic drugs. Psychopharmac. Ser. 9:1990;826-836.
59. Hirsch S. R., Richardson-Andrews R., Costall B., Kelly M. E., de Belleroche J., Naylor R. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic functions. Psychopharmacology. 93:1987;101-104.
60. Hirvonen A. Ornithine decarboxylase activity and the accumulation of its mRNA during early stages of liver regeneration. Biochim. Biophys. Acta. 23:1989;120-123.
61. Holsboer F., Barden N. Antidepressants and hypothalamo-pituitary-adrenocortical regulation. Endocrine Rev. 17:1996;187-205.
62. Hougaard D. M. Polyamine cytochemistry: localization and possible functions of polyamines. Int. Rev. Cytol. 138:1992;51-88.
63. Hougaard D. M., Larsson L.-I. Polyamine cytochemistry. Use of a novel o-phthalaldehyde method for visualizing spemidine and spermine. Comparisons to the formaldehyde-fluorescamine method. Histochemistry. 76:1982;247-256.
64. Hougaard D. M., Larsson L. I. Polyamines, molecules necessary for cell division, colocalize witgh peptide growth factors. Eur. J. Cell Biol. 48:1989;14-18.
65. Hougaard D. M., Fujiwara K., Larsson L.-I. Immunocytochemical localization of polyamines in normal and neoplastic cells. Comparisons to the formaldehyde-fluorescamine and o-phthtalaldehyde methods. Histochem. J. 19:1987;643-650.
66. Huff K. R., Schreier W., Ibric L. Proliferation-related responses in rat astrocytes to epidermal growth factor. Int. J. Dev. Neurosci. 8:1990;255-266.
67. Ichikawa M., Maeda T., Handa J. Ornithine decarboxylase in developing brain of normal and hydrocephalic rats. Biochemical and immunohistochemical studies. Childs Nerv. Syst. 13:1997;578-583.
68. Isomaa V. V., Pajunen A. E. I., Bardin C. W., Jänne O. A. Ornithine decarboxylase in mouse kidney. Purification, characterization and radioimmunological determination of the enzyme. J. Biol. Chem. 258:1983;6735-6740.
69. Jakob H., Beckmann H. Prenatal development disturbances in the limbic allocortex in schizophrenics. J. Neural Transm. 98:1986;83-106.
70. Jänne J., Pösö H., Raina A. Polyamines in rapid growth and cancer. Biochim. Biophys. Acta. 473:1978;241-293.
71. Jänne J., Alhonen L., Leinonen P. Polyamines: from molecular biology to clinical application. Ann. Med. 23:1991;241-259.
72. Junttila T., Hietala-Pettola M., Rechardt L., Persson L., Hökfelt X., Pelto-Huikko M. Ornithine decarboxylase-like immunoreactivity in rat spinal motoneurons and motoric nerves. Brain Res. 609:1993;149-153.
73. Junttila T., Rechardt L., Pelto-Huikko M. The expression of ornithine decarboxylase antizyme mRNA and protein in rat motoneurons. Neurosci. Lett. 197:1995;187-190.
74. Kajander E. O., Kauppinen L. T., Pajula R. L., Karkola K., Eloranta T. O. Purification and partial characterization of human polyamine synthase. Biochem. J. 259:1989;879-886.
75. Kauppinen R. A., Alhonen L. I. transgenic animals as models in the study of the neurobiological role of polyamines. Progr. Neurobiol. 47:1995;545-563.
76. Keinanen R., Miettinen S., Yrjanheikki J., Koistinaho J. Induction of ornithine decarboxylase mRNA in transient focal cerebral ischemia in the rat. Neurosci. Lett. 239:1997;69-72.
77. Kish S. J., Wilson J. M., Fletcher P. J. The polyamine synthesis inhibitor alpha-difluoromethylornithine is neuroprotective against N-methyl-D-aspartate-induced brain damage in vivo. Eur. J. Pharmac. 209:1991;101-103.
78. Kitani T., Fujisawa H. Alpha-difluoromethylornithine does not bind to ornithine decarboxylase-antizyme complex. Biochem. Biophys. Res. Commun. 137:1986;1101-1105.
79. Kitani T., Fujisawa H. Optimized conditions for the binding of alpha-difluoromethylornithine to ornithine decarboxylase. Biogenic Amines. 3:1986;279-285.
80. Koenig H., Goldstone A. D., Lu C. Y. Blood-brain barrier breakdown in cold injured brain is linked to a sbiphasic stimulation of ornithine decarboxylase and polyamine synthesis: both are coordinately inhibited by verapramil, dexamthasone, and aspirin. J. Neurochem. 52:1989;101-109.
81. Korhonen V. P., Halmekyto M., Kauppinen L., Myohanen S., Wahlfors J., Keinanen T., Hyvonen T., Alhonen L., Elorantam T., Jänne J. Molecular cloning of a cDNA encoding human spermine synthase. DNA Cell Biol. 14:1995;841-847.
82. Laitinen S. I., Laitinen P. H., Hietala O. A., Pajunen A. E. I., Piha R. S. Developmental changes in mouse brain polyamine metabolism. Neurochem. Res. 7:1982;1477-1485.
83. Laitinen P. H., Huhtinen R.-L., Hietala O. A., Pajunen A. E. I. Ornithine decarboxylase activity in brain regulated by a specific macromolecule, the antizyme. J. Neurochem. 44:1985;1885-1891.
84. Laitinen P. H., Hietala O. A., Pullka A. E., Pajunen A. E. I. Purification of mouse brain ornithine decarboxylase reveals its presence as an inactive complex with antizyme. Biochem. J. 236:1986;613-616.
85. Lapchak P. A. Therapeutic potential for nerve growth factor in Alzheimer's disease. Insights from using lesioned central cholinergic neurons. Rev. Neurosci. 3:1992;109-119.
86. Larsson L. I., Morch-Jörgensen L., Hougaard D. M. Cellular and subcellular localization of polyamines: cytochemical methods providing new clues to polyamine function in normal and neoplastic cells. Histochemistry. 76:1982;159-174.
87. Laschet J., Grisar T., Bureau M., Guillaume D. Chararcteristics of putrescine uptake and subsequent GABA formation in primary cultured astrocytes from normal C57Bl/6J and epileptic DBA/2J mousebrain cortices. Neuroscience. 48:1992;151-157.
88. Laschet J., Trottier, Grisar T., Leviel V. Polyamine metabolism in epileptic cortex. Epilepsy Res. 12:1992;151-156.
89. Laube G., Veh R. W. Astrocytes, not neurons, show most prominent staining for spermidine/spermine-like immunoreactivity in the adult rat brain. Glia. 19:1997;171-179.
90. Li G., Regunathan S., reis D. J. Agmantine is synthesized by a mitochondrial arginine decarboxylase in rat brain. Ann. N.Y. Acad. Sci. 763:1995;325-329.
91. Lipska B. K., Jaskiw G. E., Weinberger D. R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 9:1993;67-75.
92. Lukkarinen J., Gröhn O. H. J., Sinevirta R., Järvinen A., Kauppinen R. A., Jänne J., Alhonen L. I. Transgenic rats as models for studying the role of ornithine decarboxylase expression in permanent middle cerebral artery occlusion. Stroke. 28:1997;639-645.
93. Maeda M., Sugiyama T., Akai F., Jikihara I., Hayashi Y., Takagi H. Single stranded DNA as an immunocytochemical marker for apoptotic change of ischemia in the gerbil hippocampus. Neurosci. Lett. 240:1998;69-72.
94. Marksteiner J., Prommegger R., Sperk G. Effect of anticonvulsant treatment on kainic acid-induced increases in peptide levels. Eur. J. Pharmac. 181:1990;241-246.
95. Markwell M. A. K., Berger S. P., Paul S. M. The polyamine synthesis inhibitor alpha-difluoromethylornithine blocks NMDA-induced neurotoxicity. Eur. J. Pharmac. 182:1990;607-609.
96. Matsufuji S., Miyazaki Y., Kanamoto R., Kameji T., Murakami Y., Baby T. G., Fujita K., Ohno T., Hayashi S. Analyses of ornithine decarboxylase antizyme mRNA with cDNA cloned from rat liver. J. Biochem. (Tokyo). 108:1990;365-371.
97. McIntyre D. C., Racine R. J. Kindling mechanisms: current progress on a experimental epilepsy model. Prog. Neurobiol. 27:1986;1-12.
98. Metcalf B. W., Bey P., Danzin C., Jung M. J., Casara P., Vevert J. P. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc. 100:1978;2551-2553.
99. Modell S., Lauer C. J., Holsboer F. Hormonal response pattern in the combined Dex-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology. 18:1988;253-262.
100. Monti M. G., Ghiaroni S., Pernecco L., Barbieri D., Marverti G., Franceschi C. Polyamine depletion protects HL-60 cells from 2-deoxy-D-ribose-induced apoptosis. Life Sci. 62:1998;799-806.
101. Morisset J., Sarfati P., Grondin G. Immunocytochemical demonstration of ornithine decarboxylase in the rat exocrine oancreas using the protein-A-gold technique. Can. J. Pharmac. 64:1986;444-448.
102. Morrison L. D., Kish S. J. Brain polyamine levels are altered in Alzheimer's disease. Neurosci. Lett. 197:1995;5-8.
103. Morrison L. D., Becker L., Kish S. J. S-Adenosylmethionine decarboxylase in human brain. Regional distribution and influence of aging. Brain Res. Dev. Brain Res. 73:1993;237-241.
104. Morrison L. D., Bergeron C., Kish S. J. Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease. Neurosci. Lett. 154:1993;141-144.
105. Morrison L. D., Sherwin A. L., Carmant L., Kish S. J. Activity of S-adenosylmethionine decarboxylase, a key regulatory enzyme in polyamine biosynthesis, is increased in epileptogenic human cortex. Arch. Neurol. 51:1994;581-584.
106. Morrison L. D., Becker L., Ang L. C., Kish S. J. Polyamines in human brain: regional distribution and influence of aging. J. Neurochem. 65:1995;636-642.
107. Morrison L. D., Smith D. D., Kish S. J. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J. Neurochem. 67:1996;1328-1331.
108. Müller, M. (1991) Regional and subcellular distribution of ornithine decarboxylase during the development of the central nervous system. An immunohistochemical study. Ph.D. Thesis, Martin Luther University, Halle, pp. 1-126 (in German).
109. Müller M., Bernstein H.-G., Järvinen M., Pajunen A., Novak R., Dorn A. Ornithine decarboxylase in the inner ear of the guinea pig. Brain Res. Bull. 21:1988;1-5.
110. Müller M., Bernstein H.-G., Aurin H., Jävinen M., Pajunen A. Ornithine decarboxylase in the pituitary gland. A comparative study. Cell. Mol. Biol. 37:1991;119-124.
111. Müller M., Cleef M., Röhn G., Bonnekoh P., Pajunen A. E. I., Bernstein H.-G., Paschen W. Ornithine decarboxylase in reversible cerebral ischemia: an immunohistochemical study. Acta Neuropathol. 83:1991;39-45.
112. Müller M., Pajunen A., Poeggel G., Bernstein H.-G. Immunohistochemical localization of L-ornithine decarboxylase and its antizyme in rat brain. Mol. Biol. Cell. 3:1992;2083.
113. Müller M., Bernstein H.-G., Järvinen M., Pajunen A., Keilhoff G., Wolf G., Schwarzberg H., Reiser M. Ornithine decarboxylase in normal and disturbed brain development. Acta Histochem. Suppl. 42:1992;239-244.
114. Müller M., Bernstein H.-G., Reiser M., Järvinen M., Pajunen A. E. I. Ornithine decarboxylase expression in transplants grown in the anterior eye chamber. J. Hirnforsch. 33:1992;142.
115. Müller M., Pajunen A., Järvinen M., Poeggel G., Bernstein H.-G. Immunohistochemical demonstration of L-ornithine decarboxylase enzyme protein in different areas of the developing human brain. Dev. Neurosci. 15:1993;87-93.
116. Müller, M., Bernstein, H.-G., Poeggel, G. and Pajunen, A. E. I. (1993b) A possible role of the ornithine decarboxylase/polyamine system in blood-brain barrier organization as proposed from immunocytochemical enzyme localization. In: CNS Barriers and Modern CSF Diagnostics, pp. 177-180. Eds. K. Felgenbauer, M. Holzgraefe and H. W. Prange. VCH Verlagsgesellschaft, Weinheim.
117. Müller M., Reiser M., Bernstein H.-G., Pajunen A.E.I., Poeggel G. Ornithine decarboxylase in the adult hippocampus: immunohictochemical localization and biochemical investigations on intracellular signal cascades. J. Neurochem. Suppl. 61:1993;S103C.
118. Munis J. R., Steiner J. T., Ruat M., Snyder S. H. Diamino oxidase induces neurite outgrowth in chick dorsal root ganglia by a nonenzymatic mechanism. J. Neurochem. 70:1998;1323-1326.
119. Nemeth, G., Cintra, A., Fuxe, K., Persson, L., Agnati, L. F., Goldstein, M. and Hoyer, S. (1989) Immunocytochemical studies on some brain regions in rat model of incomplete ischemia. Relationship to behaviour and aging. In: Cerebral Ischemia and Calcium, pp. 83-86. Eds. A. Hartmann and W. Kuschinsky. Springer-Verlag, Berlin.
120. Oka T., Perry J. W., Takemoto T., Sakai T., Tereda N., Inoue H. The multiple regulatory roles of polyamines in the hormonal induction of mammary gland development. Adv. Polyamine Res. 3:1981;309-320.
121. Olney J., Faber N. B. Discussion of Bogert's temporolimbic system theory of paranoid schizophrenia. Schizophr. Bull. 23:1997;533-536.
122. 3H]-noradrenaline uptaje studies using tissue transplantations to the anterior chamber of the eye. Acta Physiol. Scand. Suppl. 348:1970;1-112.
123. Onoue H., Matsufuji S., Nishijama M., Murakami Y., Hayashi S. Changes in ornithine decarboxylase and antizyme activities in developing mouse brain. Biochem. J. 250:1988;797-803.
124. Orzi F., Zoli M., Passarelli F., Ferraguti F., Fieschi C., Agnati L. F. Repeated electroconvulsive shock increases glial fibrillary acidic protein, ornithine decarboxylase, somatostatin and cholecystokinin immunoreactivities in the hippocampal formation of the rat. Brain Res. 533:1990;223-231.
125. Pajunen A. E. I. Polyamine metabolism in mouse brain. Acta Univ. Ouluenis. 99:1979;1-118.
126. Pajunen A. E. I., Hietala O. A., Barruch-Virransalo E.-L., Piha R. S. Ornithine decarboxylase and adenosyl-methionine decarboxylase in mouse brain - affect of electrical stimulation. J. Neurochem. 30:1978;281-283.
127. Palmer A. M., Burns M. A. Preservation of polyamine and redox modulatory domains of the N-methyl-D-aspartate receptor in Alzheimer's disease. J. Neurochem. Suppl. 61:1993;S175.
128. Paschen W. Polyamine metabolism in different pathological states of the brain. Mol. Chem. Neuropathol. 16:1992;241-271.
129. Paschen W., Schmidt-Kastner R., Djuricic B., Meese C., Linn F., Hossmann K.-A. Polyamine changes in reversible cerebral ischemia. J. Neurochem. 49:1987;35-37.
130. Paschen W., Csiba L., Röhn G., Bereczki D. Polyamine metabolism in transient focal ischemia of rat brain. Brain Res. 566:1991;354-357.
131. Pegg A. E., McCann P. Polyamine metabolism and function: a review. Am. J. Physiol. 243:1982;C212-221.
132. Pegg A. E., Seely J. E., Poso H., della Ragione P., Zagon I. A. Polyamine biosynthesis and interconversion in rodent tissues. Fed. Proc. 41:1982;3065-3072.
133. Persson L., Rosengren E., Sundler F. Localization of ornithine decarboxylase by immunocytochemistry. Biochem. Biophys. Res. Commun. 104:1982;1196-1201.
134. Persson L., Rosengren E., Sundler F., Uddman R. Immunocytochemical localization of ornithine decarboxylase. Methods Enzymol. 94:1983;166-169.
135. Persson L., Holm I., Heby O. Translational regulation of ornithine decarboxylase by polyamines. FEBS Lett. 205:1986;175-178.
136. Pietala M., Alhonen I., Halmetyko M., Kanter P., Jänne J., Porter C. W. Activation of polyamine catabolism profoundly alters tissue polyamine pools and affects hair growth and female fertility in trangenic mice overexpressing spermidine/spermine N1-acetyltransferase. J. Biol. Chem. 272:1997;321-324.
137. Pujic Z., Matsumoto I., Wilce P. A. Expression of the genes coding for ornithine decarboxylase and its regulatory protein antizyme in the developing rat brain. Dev. Neurosci. 17:1995;286-291.
138. Quemener V., Moulinoux J. P., Havouis R., Seiler N. Polyamine deprivation enhances antitumoral efficacy of chemotherapy. Anticancer Res. 12:1992;1447-1453.
139. Ramchand C. N., Das I., Gliddon A., Hirsch S. R. Role of polyamines in the membrane pathology of schizophrenia. A study using fibroblasts from schizophrenic patients and normal controls. Schizophr. Res. 13:1994;227-234.
140. Richardson-Andrews R. C. A central role for the polyamines in the aetiology for schizophrenia. Med. Hypotheses. 11:1983;157-166.
141. Rosenthal A. Autotransplants for Parkinson's disease. Neuron. 20:1998;169-172.
142. Russell D. H. Ornithine decarboxylase as a biological and pharmacological tool. Pharmacology. 20:1980;117-129.
143. Russell D. H. Clinical relevance of polyamines. Crit. Rev. Clin. Lab. Sci. 18:1983;261-311.
144. Sargent-Jones L., Ganger L. L., Davis J. N., Slotkin T. A., Bartolome J. V. Postnatal development of brain alpha-adrenergic receptors: in vitro autoradiography with (125 I) HEAT in normal rats and rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase. Neuroscience. 15:1985;1195-1202.
145. Sauer D., Martin P., Allegrini P. R., Bernasconi P., Amacker H., Fagg G. E. Differing effects of alpha-difluoromethylornithine and CGP 40116 on polyamine levels and infarct volume in rat model of focal cerebral ischemia. Neurosci. Lett. 141:1992;131-135.
146. Sauerbeck, M. (1993) Ornithine decarboxylase of human WISH cells subjected to arginylating processes. Ph.D. Thesis, Eberhard Karl Univerisity, Tübingen, pp. 1-176 (in German).
147. Schipper R. G., Rutten R. G., Sauerbeck M., Schielen W. J., Adams P. J., Kopitz J., Bohley P., Tesser G. I., Verhofstad A. A. Preparation and characterization of monoclonal antibodies against ornithine decarboxylase. J. Immun. Meth. 161:1993;205-215.
148. 3H]alpha-difluoromethylornithine. Neuroscience. 27:1988;453-464.
149. Seidl R., Beninati S., Cairns N., Singewald N., Risser D., Bavan H., Nemethova M., Lubec G. Polyamines in frontal cortex of patients with Down syndrome and alzheimer disease. Neurosci. Lett. 206:1996;193-195.
150. Seiler N. Polyamine oxidase, properties and functions. Progr. Brain Res. 106:1995;333-344.
151. Seiler N., Bolkenius F. N. Polyamine reutilisation and turnover in brain. Neurochem. Res. 10:1985;529-544.
152. Seiler N., Sarhan S., Roth-Schechter B. F. Polyamines and the development of isolated neurons in cell culture. Neurochem. Res. 9:1984;871-886.
153. Seiler N., Knodgen B., Bartholeyns J. Polyamine metabolism and polyamine secretion in normal and tumor bearing rodents. Anticancer Res. 5:1985;371-377.
154. Seiler N., Delcros J. G., Moulinoux J. P. Polyamine transport in mammalian cells. An update. Int. J. Biochem. Cell. Biol. 28:1996;843-861.
155. Skashan E. G., Haraszti J. H., Snyder S. H. Polyamines: developmental alterations in regional disposition and metabolism in rat brain. J. Neurochem. 20:1973;1443-1452.
156. Slotkin T. A. Ornithine decarboxylase as a tool in developmental neurobiology. Life Sci. 24:1979;1623-1630.
157. Slotkin T. A., Bartolome J. Role of ornithine decarboxylase and the polyamines in nervous system: a review. Brain Res. Bull. 17:1986;307-320.
158. Sparapani M., Dall's Olio R., Gandolfi O., Ciani E., Contestabile A. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells. Exp. Neurol. 148:1997;157-166.
159. Stumpf W. E., Heiss C., Sar M., Duncam G. E., Craver C. Dexamethasone and cotricosterone receptor sites. Differential topographic distribution in rat hippocampus revealed by high resolution autoradiography. Histochemistry. 92:1989;201-210.
160. Subramaniam S., O'Conorti J., Magukawa L. M., McGonigle P. Polyamine effects on the NMDA receptor in human brain. Exp. Neurol. 130:1994;323-330.
161. Sunkara, P. S. and Prakash, N. J. (1984) Inhibitors of polyamine biosynthesis as antitumor and antimetastatic agents. In: Novel Approaches to Cancer Therapy, pp. 93-125. Ed. P. S. Sunkara. Academic Press, New York.
162. Svinarev V. I. Serum spermidine levels of schizophrenic patients. Zh. Nevropatol. Psikhiatr. 87:1987;732-734. (in Russian).
163. Tabor C. W., Tabor H. Methionine adenosyltransferase (S-adenosylmethionine synthetase) and S-adenosylmethionine decarboxylase. Adv. Enzymol. Related Areas Mol. Biol. 56:1984;251-282.
164. Tennyson V. M., Kremzner L. T., Dauth C. W., Gilman S. Chronic cerebellar stimulation in the monkey. Electron microscopic and biochemical observation. Neurology. 25:1975;650-654.
165. Terakura M., Higaki L., Matsui-Ywasa I., Kinoshita H., Otani S. Polyamine metabolism in the rat liver after orthotopic liver transplantaion. Biochim. Biophys. Acta. 1245:1995;201-214.
166. Tillakaratne N. J., Medina-kauwe L., Gibson K. M. Gamma-aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues. Comp. Biochem. Physiol. A. Physiol. 112:1995;247-263.
167. Tipnis U. R., Steiner A. L., Skiera C., Haddox M. K. Immunolocalization of ornithine decarboxylase in rat heart atria. J. Mol. Cell. Cardiol. 21:1989;743-750.
168. Torre E. R., Lothmann E., Steward D. Glial response to neuronal activity: GFAP-mRNA and proteins levels are transiently increased in the hippocampus after seizures. Brain Res. 631:1993;256-264.
169. Trout J. J., Koenig H., Goldstone A. D., Lu C. Y. Blood-brain breakdown by cold injury. Polyamine signals mediate acute stuimulation of endocytosis, vesicular transport, and microvillus formation in rat cerebral capillaries. Lab. Invest. 55:1986;622-631.
170. Trout J. J., Lu Y. C., Goldstone A. D., Sahgal S. Polyamines and NMDA receptors modulate pericapillary astrocyte swelling following cerebral cryo-injury in the rat. J. Neurocytol. 24:1995;341-346.
171. Van den Munckhof R. J. In situ heterogeneity of peroxisomal oxidase activities. Histochem. J. 28:1996;401-429.
172. Van den Munckhof R. J., Denym M., Tigchelaar-Gutter W., Schipper R. G., Verhofstad A. A., Van Noorden C. J., Fredericks W. M. In situ substrate specificity and ultrastructural localization of polyamine oxidase activity in unfixed rat tissues. J. Histochem. Cytochem. 43:1995;1155-1162.
173. Valentino T. L., Lukasiewicz P. D., Romano C. Immunocytochemical localization of polyamines in the tiger salamander retina. Brain Res. 713:1996;278-285.
174. Verrando P., Juhlin L., Lacour J. P., Ortonne J. P. Immunohistochemical localization of ornithine decarboxylase in human skin. J. Dermatol. 14:1987;112-117.
175. Williams K., Romano C., Dichter M. A., Molinoff P. B. Modulation of the NMDA receptor by polyamines. Life Sci. 48:1991;469-498.
176. Williams-Ashman H. G., Cannellakis Z. N. Polyamines in mammalian biology and medicine. Perspect. Biol. Med. 22:1979;421-453.
177. Yang-Feng T. L., Barton D. E., Thelander L., Lewis W. H., Srinivasan P. R., Franke U. Ribonucleotide reductase M2 subunit sequences mapped to four different chromosomal sites of humans and mice: functional locus identified by its amplification in hydroxyurea-resistant cell lines. Genomics. 1:1987;77-86.
178. Zagon I. S., Seely J. E., Pegg A. E. Autoradiographic localization of ornithine decarboxylase. Meth. Enzym. 94:1983;169-176.
179. Zagon I. S., McLaughlin P. J., Seely J. E. Autoradiographic localization of ornithine decarboxylase in mouse kidney by use of radiolabeled alpha-difluoromethylornithine. Cell Tissue Res. 235:1984;371-377.
180. Zini I., Zoli M., Grimaldi R., Pich E. M., Fuxe K., Agnati L. F. Evidence for a role of neosynthetized putrescine in the increase of glial fibrillary acidic protein immunoreactivity induced by a mechanical lesion in the rat brain. Neurosci. Lett. 120:1990;13-16.
181. Zoli M., Zini I., Grimaldi R., Biagini G., Agnati L. F. Effects of polyamine synthesis blockade on neuronal loss and astroglial reaction after transient forebrain ischemia. Int. J. Dev. Neurosci. 11:1993;175-181.
182. Zoli M., Pedrazzi P., Zini I., Agnati L. F. Spermidine/spermine N1-acetyltransferase mRNA levels showed marked and region-specific changes in the early phase of transient forebrain ischemia. Brain Res. Mol. Brain Res. 38:1996;122-134.
183. Zoli M., Bettuzzi S., Ferraguti F., Ingletti M. C., Zini I., Fuxe K., Agnati L., Corti A. Regional increases in ornithine decarboxylase mRNA levels in the rat brain after partial mesodiencephalic hemitransection as revealed by in situ hybridization histochemistry. Neurochem. Int. 18:1996;347-352.